Kinpeygo®
Patient Support Leaflet
Your Kinpeygo® Treatment Guide
This website is designed to support you, and your carers, with your treatment and is not a substitute for the Patient Information Leaflet (PIL) that came with your medication.
What is Kinpeygo®?
Kinpeygo® contains the active substance budesonide, a corticosteroid medicine which mainly acts locally in the intestine to reduce the inflammation associated with primary immunoglobulin A (IgA) nephropathy. Kinpeygo® is used to treat primary IgA nephropathy in adults 18 years of age or older.
How to take Kinpeygo®
Always take this medicine exactly as your doctor has told you.
Check with your doctor or pharmacist if you are not sure.
The recommended dose of Kinpeygo® is 16 mg (4 capsules of Kinpeygo® 4 mg) once daily
Take in the morning, at least 1 hour before a meal
Swallow whole with a glass of waterDo not open, crush or chew – as this could affect the release of the medicine.
The capsules have a special coating, to ensure that the medicine is released in the correct part of your gut.
If you take more Kinpeygo® than you should
If you take more Kinpeygo® than you should, talk to a doctor or pharmacist straight away. Take the carton with you. If you have taken more than you should for a long time, the possible side effects listed below may appear.
If you forget to take Kinpeygo®
If you miss a dose of Kinpeygo®, wait and take the medicine the next day as usual. Do not take a double dose to make up for a forgotten dose.
If you stop taking Kinpeygo®
Do not stop taking Kinpeygo® without discussing it with your doctor first. If you suddenly stop taking the medicine, you may become ill.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
How will my condition be monitored?
Your clinician will continue to monitor your condition over the course of your treatment.
When treatment is to be discontinued, your doctor will reduce the dose to 8 mg (2 capsules of Kinpeygo® 4 mg) once daily for the last 2 weeks of therapy. If considered necessary by your doctor, the dose may then be reduced to 4 mg once daily (1 capsule of Kinpeygo® 4 mg) for another 2 weeks.
What are the possible side effects?
Like all medicines, Kinpeygo® may cause side effects, although not everybody gets them. Tell your doctor, pharmacist or nurse if you notice any of the following side effects with this medicine:
Common (may affect up to 1 in 10 people)
- Increased blood pressure
- Swelling of arms or legs – such as ankle swelling
- Cushingoid features such as a rounded face, increased body hair, weight gain and acne
- Indigestion
- Muscle cramps
- Rash or itchy skin
- Weight gain
- Diabetes mellitus
Rare (may affect up to 1 in 1,000 people)
- Blurred vision
For full details on your treatment, please refer to the Patient Information Leaflet that comes enclosed in your Kinpeygo® medication pack.
Further Information
Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Visit https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store to see how to report side effects.
Caring for People’s Health www.thorntonross.com
Thornton & Ross Ltd, Linthwaite, Huddersfield HD7 5QH.
UK-KINPE-94 | Date of Preparation: April 2024
